{
  "abstract": "Summary points: The 2026 WHO guidelines recommending doxycycline post-exposure prophylaxis (doxy-PEP) represent the first global antibiotic prophylaxis recommendation for bacterial sexually transmitted infections (STIs), with provisions for antimicrobial resistance (AMR) monitoring.Doxy-PEP should be governed as an adaptive intervention subject to periodic, transparent review, but establishing decision rules faces challenges.Doxy-PEP is expected to select for resistance, including in Neisseria gonorrhoeae, Staphylococcus aureus, and the gut and skin microbiomes; the scope of clinical consequences is incompletely understood.As STI prevalence falls, the benefit per dose declines while the AMR externality per dose is expected to grow, shifting the cost-benefit balance in ways that vary across populations and settings.Attributing changes in disease prevalence or resistance patterns to doxy-PEP is methodologically difficult, given incompletely understood and complex drivers of pre-existing trends, surveillance limitations, and heterogeneous uptake, raising questions about study designs, data sources, eligibility criteria, and governance mechanisms.A full accounting of benefits and harms is broader than reduced bacterial STI incidence and AMR. Benefits include consideration of patient-centered outcomes such as reduced anxiety regarding STI acquisition, avoidance of repeated treatment visits, and fewer STI-related complications. Harms include drug side effects, such as gastrointestinal adverse effects and concerns about use in pregnancy. In this Policy Forum article, Yonatan Grad and colleagues discuss that while doxy-PEP has shown early success in reducing transmission of bacterial STIs, concerns regarding its contribution to antimicrobial resistance, particularly in N. gonorrhoeae, warrant close monitoring, and discuss why prospective thresholds and adaptive guidelines are needed.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America",
    "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
    "Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, World Health Organization, Geneva, Switzerland"
  ],
  "article_type": "Policy Forum",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Yonatan H. Grad",
      "orcid": "0000-0001-5646-1314"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Rachel Mittelstaedt",
      "orcid": "0009-0005-7199-3382"
    },
    {
      "affs": [
        2
      ],
      "name": "Remco P. H. Peters",
      "orcid": "0009-0007-5955-0815"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/arktq820r8yc0.bib",
  "cited_by": 0,
  "doi": "10.1371/journal.pmed.1005276",
  "fulltext_url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005276",
  "id": "arktq820r8yc0",
  "issns": [
    "1549-1676",
    "1549-1277"
  ],
  "landing_url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005276",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Antibiotics"
    ],
    [
      "heading",
      "Antimalarials"
    ],
    [
      "heading",
      "Antimicrobial Resistance"
    ],
    [
      "heading",
      "Antimicrobials"
    ],
    [
      "heading",
      "Bacteria"
    ],
    [
      "heading",
      "Bacterial Diseases"
    ],
    [
      "heading",
      "Bacterial Pathogens"
    ],
    [
      "heading",
      "Biology and Life Sciences"
    ],
    [
      "heading",
      "Biology and life sciences"
    ],
    [
      "heading",
      "Doxycycline"
    ],
    [
      "heading",
      "Drugs"
    ],
    [
      "heading",
      "Epidemiology"
    ],
    [
      "heading",
      "Genitourinary Infections"
    ],
    [
      "heading",
      "HIV"
    ],
    [
      "heading",
      "Immunodeficiency Viruses"
    ],
    [
      "heading",
      "Infectious Diseases"
    ],
    [
      "heading",
      "Lentivirus"
    ],
    [
      "heading",
      "Medical Conditions"
    ],
    [
      "heading",
      "Medical Microbiology"
    ],
    [
      "heading",
      "Medicine and Health Sciences"
    ],
    [
      "heading",
      "Microbial Control"
    ],
    [
      "heading",
      "Microbial Pathogens"
    ],
    [
      "heading",
      "Microbiology"
    ],
    [
      "heading",
      "Neglected Tropical Diseases"
    ],
    [
      "heading",
      "Neisseria"
    ],
    [
      "heading",
      "Neisseria Gonorrhoeae"
    ],
    [
      "heading",
      "Organisms"
    ],
    [
      "heading",
      "Pathogens"
    ],
    [
      "heading",
      "Pathology and Laboratory Medicine"
    ],
    [
      "heading",
      "Pharmacology"
    ],
    [
      "heading",
      "Policy Forum"
    ],
    [
      "heading",
      "RNA viruses"
    ],
    [
      "heading",
      "Retroviruses"
    ],
    [
      "heading",
      "Sexually Transmitted Diseases"
    ],
    [
      "heading",
      "Staphylococcus"
    ],
    [
      "heading",
      "Staphylococcus Aureus"
    ],
    [
      "heading",
      "Syphilis"
    ],
    [
      "heading",
      "Treponematoses"
    ],
    [
      "heading",
      "Tropical Diseases"
    ],
    [
      "heading",
      "Urology"
    ],
    [
      "heading",
      "Viral Pathogens"
    ],
    [
      "heading",
      "Viruses"
    ],
    [
      "openalex",
      "2402|Antibiotic Use and Resistance"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Medical microbiology/Microbial pathogens/Bacterial pathogens/Neisseria gonorrhoeae"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Medical microbiology/Microbial pathogens/Bacterial pathogens/Staphylococcus/Staphylococcus aureus"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Medical microbiology/Microbial pathogens/Viral pathogens/Immunodeficiency viruses/HIV"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Medical microbiology/Microbial pathogens/Viral pathogens/Retroviruses/Lentivirus/HIV"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Microbial control/Antimicrobial resistance"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Microbial control/Antimicrobials/Antibiotics/Doxycycline"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Bacteria/Neisseria/Neisseria gonorrhoeae"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Bacteria/Staphylococcus/Staphylococcus aureus"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Viruses/Immunodeficiency viruses/HIV"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Viruses/RNA viruses/Retroviruses/Lentivirus/HIV"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Viruses/Viral pathogens/Immunodeficiency viruses/HIV"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Viruses/Viral pathogens/Retroviruses/Lentivirus/HIV"
    ],
    [
      "plos",
      "/Medicine and health sciences/Epidemiology"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Bacterial diseases/Treponematoses/Syphilis"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Sexually transmitted diseases"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Sexually transmitted diseases/Syphilis"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Tropical diseases/Neglected tropical diseases/Treponematoses/Syphilis"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Pathogens/Microbial pathogens/Bacterial pathogens/Neisseria gonorrhoeae"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Pathogens/Microbial pathogens/Bacterial pathogens/Staphylococcus/Staphylococcus aureus"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Pathogens/Microbial pathogens/Viral pathogens/Immunodeficiency viruses/HIV"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Pathogens/Microbial pathogens/Viral pathogens/Retroviruses/Lentivirus/HIV"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pharmacology/Antimicrobial resistance"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pharmacology/Drugs/Antimalarials/Doxycycline"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pharmacology/Drugs/Antimicrobials/Antibiotics/Doxycycline"
    ],
    [
      "plos",
      "/Medicine and health sciences/Urology/Genitourinary infections/Syphilis"
    ]
  ],
  "openalex": "W7223158768",
  "pdf_url": "https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1005276&type=printable",
  "pmcid": "PMC13712666",
  "pmid": "42905871",
  "published": "2026-10-21",
  "publisher": "Public Library of Science",
  "ris": "https://research.draconitic.com/paper/arktq820r8yc0.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:23Z",
      "native_id": "10.1371/journal.pmed.1005276",
      "source": "plos",
      "url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005276"
    },
    {
      "first_seen": "2026-10-31T12:23:12Z",
      "native_id": "PMC13712666",
      "source": "pmc",
      "url": "https://doi.org/10.1371/journal.pmed.1005276"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "plos:microbiology",
      "subfield": "microbiology"
    },
    {
      "field": "medicine",
      "origin": "heading:Epidemiology",
      "subfield": "epidemiology-public-health"
    },
    {
      "field": "medicine",
      "origin": "plos:infectious diseases",
      "subfield": "infectious-disease"
    },
    {
      "field": "medicine",
      "origin": "plos:pharmacology",
      "subfield": "pharmacology-toxicology"
    }
  ],
  "title": "How do we monitor doxy-PEP impact and when should we consider revisiting guidelines?",
  "title_text": "How do we monitor doxy-PEP impact and when should we consider revisiting guidelines?",
  "type": "peer-reviewed",
  "updated_at": "2026-10-31T12:23:12Z",
  "url": "https://research.draconitic.com/paper/arktq820r8yc0",
  "venue": "PLOS Medicine",
  "versions": []
}